Source: BioPortfolio

Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250

SummaryJuventas Therapeutics Inc Juventas formerly AcelleRX Therapeutics Inc is a clinical stage biotechnology company that develops regenerative therapies to treat life threatening cardiovascular diseases. The company specializes in the development of nov...

Read full article »
Juventas's Competitors | Juventas's News | Juventas's Financials
Stay up-to-date with the latest news on Juventas
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Rahul Aras's photo - President & CEO of Juventas

President & CEO

Rahul Aras

CEO Approval Rating

72/100

Read more
Stay up-to-date with the latest news on Juventas